Squamous‐cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept
Squamous‐cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept
About this item
Full title
Author / Creator
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Key Clinical Message
A patient affected by rheumatoid arthritis developed a squamous‐cell carcinoma probably due to abatacept, according to Naranjo algorithm. The case describes this adverse reaction for the first time and highlights the need for additional studies to establish the long‐term risk profile of abatacept.
A patient affected by rh...
Alternative Titles
Full title
Squamous‐cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4184594
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4184594
Other Identifiers
ISSN
2050-0904
E-ISSN
2050-0904
DOI
10.1002/ccr3.56
